Oramed Pharmaceuticals Inc
About
Oramed Pharmaceuticals Inc (NASDAQ:ORMP) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 25 2026
Lifeward Successfully Closes on Strategic Partnership with Oramed
Jan 13 2026
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
Jan 13 2026
Oramed and Lifeward Announce Strategic Transaction
Jan 7 2026
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Nov 17 2025
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Financials
Revenue
$2 M
Market Cap
$138.33 M
P/E Ratio
2.28
EPS
1.50